Toxoplasma gondii: Effects on Serum Serotonin Concentration and Indoleamine 2, 3-Dioxygenase Expression

Toxoplasma gondii: Effects on Serum Serotonin Concentration and Indoleamine 2, 3-Dioxygenase Expression | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Toxoplasma gondii: Effects on Serum Serotonin Concentration and Indoleamine 2, 3-Dioxygenase Expression Elham Kordserkeche, Jasem Saki, Reza arjmand, MohammadAmin Behmanesh, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7390460/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 09 Feb, 2026 Read the published version in Acta Parasitologica → Version 1 posted 4 You are reading this latest preprint version Abstract Background Toxoplasma gondii is an obligate intracellular protozoan that infects approximately one-third of the global population. Research has increasingly suggested a connection between toxoplasmosis and alterations in behavior. This study aims to investigate the effects of T. gondii infection on serum serotonin levels and the expression of the indoleamine 2, 3-dioxygenase (IDO) gene in the brain cells of Balb/c mice. Methods A total of 72 female Balb/c mice were utilized in this study, with 36 assigned to the experimental group and 36 to the control group. The mice were further divided into six subgroups, each containing six mice. Serum serotonin levels were quantified using the ELISA method, while the expression of the IDO1 gene was assessed through quantitative real-time PCR. Results It is observed that the serotonin serum concentration in the infected Balb/c mice was substantially higher than the non-infected groups on the day 10th (371.17 ± 53.391 vs. 233.50 ± 1.225, p < 0.0001), 20th (283.33 ± 41.707 vs. 233.33 ± 1.033, p < 0.05 ), 30th (269.17 ± 36.766 vs. 233.67 ± 0.516, p < 0.05) and 40th (291.50 ± 62.956 vs. 233.67 ± 1.033, p < 0.05) post-infection, while the serotonin serum was dramatically diminished in the infected groups rather than the control mice on day 60th (197.50 ± 23.998 vs. 233.17 ± 1.472, p < 0.01). Notably, the expression of the IDO1 gene in brain cells increased by 5.65-fold on day 10 post-infection, followed by downward trends by day 40th (1.91-fold) was observed. Moreover, sharp fluctuations also took place on the 50th and 60th . Conclusion It is conclusively revealed that the serum level of serotonin and IDO1 mRNA expression were significantly higher in T.gondii infected Balb/c mice than normal control group. However, future investigations could explore therapeutic interventions targeting IDO1 or serotonin pathways to mitigate neurological impacts in chronic T.gondii infections. Serum Serotonin Indoleamine 2 3-dioxygenase Brain Toxoplasma gondii Figures Figure 1 Figure 2 Figure 3 Figure 4 1. Introduction Toxoplasma gondii ( T. gondii ) is a highly successful intracellular protozoan parasite of the Apicomplexa phylum [ 1 ]. Approximately one-third of the human population worldwide is estimated to be infected with T. gondii [ 2 ]. Felidaes, either wild or domestic ones, are considered as the ultimate hosts, while all warm-blooded, in particular, human are intermediate hosts, in which the asexual life cycle occurs [ 3 ]. Humans can contract toxoplasmosis infection by consuming oocysts contaminated food, water, fruits, and vegetables; by ingesting tissue cysts in undercooked or raw meat; and by congenital transmission from mother to fetus during pregnancy [ 4 ]. Following the infection of T. gondii in an intermediate host, sporozoites released from oocysts or bradyzoites inside tissue cysts infect enterocytes, transforming into rapidly reproducing tachyzoites that spread to many organs and tissues, resulting in an acute phase of infection. Tachyzoites transform into slowly replicating bradyzoites in reaction to the host immune system, forming cysts especially muscle and brain to develop a chronic infection. These bradyzoites develop cysts encased in a thick membrane that conceals them from the host's immune response. In final Felidae host, Bradyzoites within tissue cysts to invade enterocytes and differentiate into merozoites. Merozoites differentiate into male and female gametes, facilitating sexual reproduction and the subsequent excretion of many oocysts [ 5 ]. T.gondii infection is related to neurological and neurobehavioral disorders including Alzheimer’s disease, Parkinson's disease, depression, bipolar disorder, schizophrenia, and obsessive-compulsive disorder [ 6 ]. In the central nervous system (CNS), T. gondii can breach the blood-brain barrier (BBB) and invade several parenchymal cells, such microglia, astrocytes, and neurons, which can contribute to the inflammatory response. T. gondii infection may trigger alterations in the numbers of CD4 + T cells and cytokines like Interferon-γ (IFN-γ). IFN-γ in CNS can stimulate astrocytes to generate chemokines that facilitate the entry of CD4 + T cells into the CNS [ 7 ]. This clarifies how T. gondii interacts with the BBB and immune response, leading to a complicated infection in the CNS. IFNγ is most important cytokine in the host's anti-parasitic defense against T. gondii [ 8 ]. One of the ways that IFNγ exerts its anti-Toxoplasma effects is by stimulating the expression and activity of indoleamine 2,3-dioxygenase (IDO), which depletes L-tryptophan, an essential amino acid for the parasite's growth [ 9 ]. IDO, an intracellular heme-containing enzyme, catalyzes the first and rate-limiting step in the breakdown of L -tryptophan in the kynurenine pathway [ 10 ]. IDO exists in two forms: IDO1 and IDO2. All vertebrates possess both genes, with IDO1 found in all mammals, exhibiting a high affinity for L -tryptophan. IDO2 is present in both mammals and lower vertebrates but has a lower affinity for L -tryptophan, resulting in a reduced catalytic effect [ 11 ]. In vitro experiments revealed that IDO inhibits T. gondii growth in various mice and human cell lines [ 12 , 13 ]. A study showed that the administration of 1-methyltryptophan (1-MT), an IDO inhibitor, to mice in the chronic phases of T. gondii infection led to increased death rates associated with rising parasite loads in the brain [ 14 ]. Given that tryptophan is the precursor of serotonin, elevated IDO levels during T. gondii infection might reduce production of serotonin [ 15 ]. Serotonin (5-hydroxytryptamine, 5-HT) is both a neurotransmitter and a peripheral hormone (16). In CNS it serves as a neurotransmitter that regulates important brain functions, including mood, sleep, cognition, memory, body temperature, and stress response [ 16 , 17 ]. Peripherally, 5-HT plays a significant role in major organ systems, regulating various processes such as hemostasis, organ development, cellular regeneration, gastrointestinal motility, immunology, cardiovascular and pulmonary physiology, and among others [ 17 , 18 ]. Almost 95% of 5-HT is created by enterochromaffin cells in the gut, while the other 5% is mostly synthesized by serotonergic neurons in the central nervous system, with a smaller amount generated by adipose tissue, mammary glands, and pancreatic islets [ 19 ]. Most 5-HT in the body is circulated in the bloodstream, stored in platelets, and released upon platelet activation [ 18 ]. 5-HT has significant effects on the immune system, although research on this topic has yielded conflicting results. Some studies suggest that serotonin has pro-inflammatory properties [ 20 ], while others indicate anti-inflammatory effects [ 21 ]. It impacts various immune cells, stimulating the activation and proliferation of T lymphocytes, dendritic cells, neutrophils, B lymphocytes, and natural killer (NK) cells [ 18 ]. This study aims to evaluate IDO gene expression in brain cells and assess variations in serotonin levels in the blood of mice infected with T. gondii at various time points post-infection. Previous studies have independently explored the impact of Toxoplasma gondii on IDO expression in the brain and serotonin levels in the blood. However, research simultaneously examining the effect of Toxoplasma gondii on IDO expression in brain cells and serotonin levels remains limited. This study was therefore designed to investigate the dual impact of Toxoplasma gondii on IDO gene expression in brain cells and serum serotonin levels over a 60-day period with measurements taken at 10-day intervals. 2. Methods 2.1. Animals The study involved 84 female Balb/c mice, each weighing approximately 200 grams and aged 5 weeks. Mice were bought from the animal house of Jondishapour Medical Sciences University of Ahvaz (Iran, Ahvaz) and care in specific pathogen-free conditions. The mice were divided into two groups: 42 in the experimental group and 42 in the control group. Each group was further subdivided into six subgroups of seven mice each. The animals were housed in polypropylene cages, with 4 to 5 mice per cage, and had unrestricted access to food and water. The experimental group received an intraperitoneal injection of T.gondii bradyzoites, while the control group was injected with phosphate-buffered saline (PBS). All procedures performed on animals in this study was approved by the Animal Care and Use Committee of Ahvaz Jundishapur University of Medical Sciences (IR.AJUMS.ABHC.REC.1401.021) and adhered to National Institutes of Health guidelines. 2.2. Inoculation of Cyst-free T. gondii Parasites T.gondii Type II was isolated from young C57BL/6 mice infected via oral gavage with 10 cysts and sacrificed 4 to 5 weeks post-infection. Cyst-free parasites were prepared following established protocols. Briefly, fresh brain tissue was homogenized in 2 ml of sterile PBS using a Dounce homogenizer for one minute on ice. The homogenate was centrifuged at 2000 x g for 5 minutes at 4°C, and the supernatant was discarded. The pellet was resuspended in 20 ml of sterile 30% Percoll and centrifuged for 20 minutes at 2000 x g at 15°C with no brake. After discarding the supernatant, the pellet was treated with 100 µl of 0.25% (v/v) trypsin for 30 seconds, then diluted with 900 µl of PBS. This mixture was added to 4 ml of PBS and filtered through a 3 µm filter. Parasite concentration was determined using a hemocytometer, and each mouse received 100 parasites (0.2 ml) via intraperitoneal (IP) injection. 2.3. Sample Collection Mice from each group were anesthetized with ketamine (30–50 mg/kg) administered IP injection every 10 days, and blood and brain samples were collected. Blood samples were obtained from tail vein and put to clot activator tubes. Plasma samples were collected after centrifugation at 3000 rpm for 15 minutes at 4°C and stored at -80°C. Brains were collected and washed in sterile ice-cold PBS. The tissue samples were immediately frozen in liquid nitrogen using a tissue-freezing medium (Leica Biosystems, USA) for further analysis. 2.4. Determination of Anti- T. gondii Antibodies The presence of anti- T. gondii antibodies was assessed 10 days post-inoculation using a Mouse Toxoplasmosis (TOXO) Antibody (IgG) ELISA Kit (Novus Biologicals, USA). Optical densities (ODs) were measured at λ = 450 nm on two wells per sample using a BioTek SP2 microplate reader (USA). 2.5. Histopathological Studies Brain tissues were fixed in 10% formalin solution, then embedded in paraffin, and sectioned to a thickness of 5–7 µm. Serial sagittal sections were stained with hematoxylin and eosin (H&E). 2.6. Analysis of Serum 5-HT Concentration Serum 5-HT levels were quantified using BioVision's Serotonin ELISA Kit (Milpitas Blvd., Milpitas, CA 95035, USA), a competitive ELISA assay. Standards were processed according to the reference protocol for each assay. OD values for the standards were used to create a semi-logarithmic reference curve, allowing the 5-HT content of each serum sample to be extrapolated from its corresponding OD value. 2.7. Gene expression analysis The mRNA levels of IDO were assessed by quantitative real-time polymerase chain reaction (qRT–PCR) (Fig. 1 ). Total RNA was isolated from the cerebral cortex and striatum using an RNeasy Mini Kit (Qiagen, Germany) according to mentioned protocol. The concentration of extracted RNAs was quantified utilizing a NanoDrop spectrophotometer (Thermo Scientific NanoDrop). Reverse transcription of 1 µg of total RNA to complementary DNA (cDNA) was carried out employing the ExcelRT™ Reverse Transcription Kit (SMOBIO, Taiwan) in accordance with the manufacturer's instructions. The qRT-PCR was run with the TaKaRa PCR Amplification Kit (Takara Bio Inc., Japan) and primers and carried out on a StepOne Plus Real-Time PCR system (Applied Biosystems, Branchburg, New Jersey). Each PCR reaction (20 µl) contained 1 µl of cDNA, 6.25 µl of QPCR Master Mix SYBR Green, 0.25 µl of each primer, and 4.75 µl of distilled water. The PCR cycles consisted of an initial 5 minutes at 95°C, followed by 40 cycles of 15 seconds at 95°C, 20 seconds at 60°C, and 20 seconds at 72°C. Gene expression was normalized to the GAPDH, a housekeeping gene. Gene expression levels were calculated using the 2 −ΔΔCt method. The specific primer sequences were as follows: - IDO1 Forward: 5’-CCTTCTGGGAATAAAACACGAGG-3’ Reverse: 5’-CTAAGAAGA AAAGGAAGTTCCGG-3’ - IDO2 Forward: 5’-ATCTCCACGTAGCTCCTTCT-3’ Reverse: 5’-GCCTCCACACACTGGTTATAG-3’ - GAPDH Forward: 5’-GGTCACCAGGGCTGCTTTTA-3’ Reverse: 3’ -CCGTTCTCAGCCATGTAGT- 5’ 2.8. Statistical Analysis The levels of serotonin and IDO1 mRNA gene expression folding changes were reported as mean ± standard deviation (SD) and Data were measured in triplicate. The 2 –ΔΔCt method was also implemented to calculate the IDO1 mRNA gene expression folding changes Student t-test and two-way ANOVA tests were employed for comparison between unpaired and within the study groups, respectively. P-values less than 0.05 were considered as significant level. P-values < 0.05 (*), P-values < 0.01 (**), P-values < 0.001 (***) and P-values < 0.0001 (****). All calculations were performed using the GraphPad Prism software (GraphPad Software Inc., San Diego, CA, USA). 3. Results 3.1. Temporal Profiles of IDO Induction and 5-HT Concentration Alteration in Balb/c Mice Infected with T. gondii We assessed the time course of changes in the serum levels of serotonin and IDO1 mRNA expression in the brains of Balb/c mice infected with T. gondii . It is observed that the serotonin serum concentration in the infected Balb/c mice was substantially higher than the non-infected groups on the day 10th, 20th, 30th and 40th post-infection, while the serotonin serum was dramatically diminished in the infected groups rather than non-infected mice on day 60th. Serotonin serum levels in the infected and non-Infected mice at different time points are depicted in Fig. 2 . The mRNA levels of the two IDO isoforms ( IDO1 and IDO2 ) were assessed in these mice. Notably, the expression of the IDO1 gene in brain cells increased by 5.65-fold on day 10 post-infection, followed by a slight decrease until day 30th. On day 40th, a drastic reduction of 1.91-fold was observed, but an increase of 4.8-fold taken place on day 50th. However, by day 60th, a considerable attenuation of 1.29-fold occurred (Fig. 3 ). Notably, no mRNA expression of IDO2 was detected. 3.2. Pathological Results Twenty-day post-infection, tissue cysts were detected in the brains of Balb/c mice. By day 40th, some mice exhibited ruptured tissue cysts (Fig. 4 ). In contrast, no cysts were observed in any mice from the control group. 4. Discussion The findings of this study revealed that not only there is a significant increase in the serotonin serum concentration in the T.gondii infected mice group by the 40th day post-infection compared to the control group but also the IDO1 mRNA expression folding change was noticeable in the brain of Balb/c infected mice pertinent to the control group. The surge in serotonin may be linked to the activation of platelets, known to store serotonin and release it upon activation. The initial boost in serotonin levels suggests that the immune response to tachyzoites in the bloodstream may be intense during this stage, as platelets play an essential role in immune defense and inflammation. On the 10th day after infection, tachyzoites increased the concentration of serum serotonin by entering the blood and probably by the induction of platelets, which are the storage source of serotonin, and during that period of time, a part of tachyzoites probably went to the brain and interacted with cells. Cerebral induction caused the expression of IDO1. The increase in the expression of this gene was accompanied by a decrease in serum serotonin levels on the 20th and 30th days. On the 20th and 30th days, the expression of IDO 1 decreased, and on the 40th day, we observed the amplification in the concentration of serum serotonin levels, which was associated with a more decrease in IDO1 gene in this period. Continuing to measure serum serotonin and IDO1 gene expression in the brain showed that on the 50th day, the level of serum serotonin decreased and the expression of the IDO1 gene increased. By examining the pathology of the brain tissue, we observed that tissue cysts were ruptured on the 40th day, and this is probably the cause and this was probably the reason for the IDO1 gene expression to be reactivated and show a significant increase after 10 days of measurement, on the 50th day. After that and on the 60th day, the measurements of the two mentioned parameters showed that they both decreased on the 60th day. This finding aligns with numerous studies investigating the effects of T.gondii on blood serotonin levels and related gene expression. For instance, research by Castello et al. demonstrated that serotonin levels in the blood of 17 sheep with anti- Toxoplasma antibodies were significantly higher than in the control group, with infected sheep exhibiting greater platelet and monocyte counts [ 22 ]. Similarly, Pastre et al. reported elevated expression of the 5-HT, ICAM1, Type II collagen, and total mast cell genes in rats infected with sporulated oocysts of T. gondii [ 23 ]. This study somehow highlighted a strong correlation between mast cell migration to the infection site and increased expression of ICAM1 and 5-HT during peak infection. In another study, Pastre et al. found that acute infection with T. gondii oocysts in mice preferentially activates non-neuronal cells to secrete serotonin [ 24 ]. Their findings suggested that T. gondii manipulates the jejunal epithelium to activate the immune system, including mast cells. An increase in enterochromaffin cells and mast cells expressing serotonin was also noted in the jejunum wall. According to Casagrande et al., serotonin expression levels are associated with moderate intestinal immunomodulation following acute infection with T. gondii oocysts in C57BL/6 mice [ 25 ]. Mucus from infected mice showed a marked increase in serotonin-immunoreactive cells. Strikingly, T. gondii multiplies as a tachyzoite within nucleated cells after entering the host. Once the immune response is overcome, it transforms into an inactive bradyzoite, forming tissue cysts in various organs, primarily the brain, where they can remain dormant [ 26 ]. In response to infection, macrophages produce the cytokine IL-12, which prompts natural killer cells to produce interferon gamma (IFN-γ) [ 27 ]. IFN-γ inhibits the intracellular proliferation of the parasite in human and mouse cells, with mice lacking IFN-γ being unable to control T. gondii growth. Various studies have demonstrated that IFN-γ exerts anti- T. gondii effects in human cells, such as macrophages, fibroblasts, and microglial cells, by inducing indoleamine 2,3-dioxygenase (IDO). IDO is expressed in microglial cells in the brain and is responsible for tryptophan degradation, serving as a defense mechanism against T. gondii [ 28 ]. In current study throughout the 60-day period, complex interactions between the parasite and host responses were observed. In the acute phase of toxoplasmosis, IDO1 expression appears to be stimulated, while its levels decline when T. gondii enters the chronic phase. Ufermann et al. reported a definite induction of IDO1 during acute murine toxoplasmosis in their experimental model [ 29 ]. Other studies have also demonstrated IDO1 expression in mice infected with T. gondii , with IDO activation leading to increased and earlier mortality in Huntington disease mice [ 30 ]. Fujigak et al. found significantly higher levels of IDO enzyme activity and IDO mRNA in the brains and lungs of C57BL/6 mice compared to those lacking IFN-γ [ 28 ]. Their findings suggest that inducible nitric oxide synthase (iNOS) and IDO are cross-regulated in an anti- T. gondii manner. In this study, we observed a significant increase in IDO1 gene expression shortly after infection, followed by fluctuations over the subsequent 10-day intervals. This pattern suggests that the initial entry of T. gondii tachyzoites into the brain triggers an immune response, activating the kynurenine pathway. The upregulation of the IDO1 enzyme appears to be a strategy to deprive the parasite of tryptophan, an amino acid essential for parasite growth [ 31 ]. IDO1 has been shown to play a significant role in immune regulation during infection, as its upregulation can lead to tryptophan catabolism, thus limiting the parasite's availability of this critical resource. The decline in gene expression on days 20th, 30th, and 40th likely corresponds to the parasite transitioning into its chronic and inactive phase. The increase in expression on day 50th suggests reactivation of the parasite, overcoming the host's immune defenses, which can often occur after a period of dormancy or immune evasion [ 32 ] . Examination of the brains of infected mice revealed ruptured cysts on day 40th, indicating parasite reactivation, which was associated with increased IDO1 expression that subsequently decreased again after 10 days [ 33 ]. This temporal pattern of IDO1 regulation has been linked to the host's immune response and parasite reactivation dynamics [ 34 ]. This timeline demonstrates how Toxoplasma gondii infection influences host biochemistry, particularly serotonin levels, through an immune-mediated mechanism involving IDO1. These fluctuations in serotonin, driven by immune responses and parasite behavior, could have significant physiological and neurological consequences. For instance, as serotonin is a key neurotransmitter involved in mood regulation, its depletion during infection phases might explain behavioral changes in infected hosts. Additionally, the study provides profound insights into how the immune response adapts from an acute phase, characterized by high serotonin turnover and IDO1 activation, to a chronic phase where the immune response stabilizes as tissue cysts form. Similar to other studies, this study includes some strength and limitation points. The current study is the first one, within which we checked the serotonin concentration and relative expression of IDO1 in T.gondii infected Balb/c mice by day 60 post-infection, which can take into account as a novelty of this investigation. However, some limitations and suggestions are observed as follows: 1) the measurement of inflammatory cytokines, particularly IFN-γ in the blood and brain, could not be conducted; 2) Regarding the IDO can impact on anti-inflammatory cytokines secretion such as tumor growth factor beta and interleukin 10, the assessment of these cytokine fluctuations in the blood and brain of the infected mice during the post-infection period may have a beneficiary for evaluation and modulation of inflammatory response. 3) Given that regulatory T cells occupy a prominent role in IDO secretion, the evaluation of this immune cell subset frequency can be fruitful in this context. 5. Conclusion Overall, this infection timeline reflects the complex interactions between a pathogen and host defenses, affecting both the brain and systemic biochemistry. It is revealed that the serum level of serotonin and IDO1 mRNA expression were significantly higher in T.gondii infected Balb/c mice than normal control group. However, future investigations could explore therapeutic interventions targeting IDO1 or serotonin pathways to mitigate neurological impacts in chronic T.gondii infections. Declarations Ethics statement The Animal Care and Use Committee of Ahvaz Jundishapur University of Medical Sciences (IR.AJUMS.ABHC.REC.1401.021) approved this study and all procedures used for animal experiments. Consent to participate All authors participated to the research described in this study. Consent for publication All authors gave their consent for the research described in this study to be published. CRediT authorship contribution statement Elham Kordserkeche: Conducting experiments, writing – review & editing, writing original draft; Jasem Saki: Conceptualization; Reza Arjmand: Data curation; Mohammad Amin Behmanesh: Methodology; Saeedeh Shojaee: Methodology. Declaration of competing interest None. Funding This research was supported by Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (grant number: CMRC-0106). Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Acknowledgments This study originates from the thesis of a Ph.D. student, Elham Kordserkeche, granted by Ahvaz Jundishapur University of Medical Sciences (CMRC-0106). We feel it necessary to express our sincere gratitude to Dr. Tabandeh from Shahid Chamran Ahvaz University for his valuable assistance. Transparency Statement The corresponding author, Dr. Jasem Saki approve that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been discarded; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. References Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Tanzifi A et al (2018) Drug Resistance in Toxoplasma gondii. Front Microbiol 9:2587. https://doi.org/10.3389/fmicb.2018.02587. Dubey JP (2009) History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol 39:877-882. https://doi.org/10.1016/j.ijpara.2009.01.005. Afonso C, Paixão VB, Klaus A, Lunghi M, Piro F et al (2017) Toxoplasma-induced changes in host risk behaviour are independent of parasite-derived AaaH2 tyrosine hydroxylase Sci Rep 7:13822. https://doi.org/10.1038/s41598-017-13229-y. Nasiru Wana M, Mohd Moklas MA, Watanabe M, Nordin N, Zasmy Unyah N et al (2020) A Review on the Prevalence of Toxoplasma gondii in Humans and Animals Reported in Malaysia from 2008–2018. Int J Environ Res Public Health 17:4809. https://doi.org/10.3390/ijerph17134809. Sharma J, Rodriguez P, Roy P, Guiton PS (2020) Transcriptional ups and downs: patterns of gene expression in the life cycle of Toxoplasma gondii. Microbes Infect 22:525-533. https://doi.org/ 10.1016/j.micinf.2020.09.001. Virus MA, Ehrhorn EG, Lui LM, Davis PH (2021) Neurological and Neurobehavioral Disorders Associated with Toxoplasma gondii Infection in Humans. J Parasitol Res 2021:6634807. https://doi.org/10.1155/2021/6634807. Wang Q, Zhong Y, Chen N, Chen J (2023) From the immune system to mood disorders especially induced by Toxoplasma gondii: CD4+ T cell as a bridge. Front Cell Infect Microbiol 13:1078984. https://doi.org/10.3389/fcimb.2023.1078984. Hunt NH, Too LK, Khaw LT, Guo J, Hee L et al (2017) The kynurenine pathway and parasitic infections that affect CNS function. Neuropharmacology 112:389-398. https://doi.org/10.1016/j.neuropharm.2016.02.029. Tedford E, McConkey G (2017) Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection. Pathogens 6:19. https://doi.org/10.3390/pathogens6020019. Bello C, Heinisch PP, Mihalj M, Carrel T, Luedi MM (2021) Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System. Front Physiol 12:766511. https://doi.org/10.3389/fphys.2021.766511. Yuasa HJ, Ball HJ, Ho YF, Austin CJ, Whittington CM et al (2009) Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases: IDOs from monotremes and marsupials. Comp Biochem Physiol B Biochem Mol Biol 153:137-44. Schmidt SK, Ebel S, Keil E, Woite C, Ernst JF et al (2013) Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions. PLoS One 8:e63301. https://doi.org/10.1371/journal.pone.0063301. Anand N, Lutshumba J, Whitlow M, Abdelaziz MH, Mani R, Suzuki Y (2022) Deficiency in indoleamine-2, 3-dioxygenase induces upregulation of guanylate binding protein 1 and inducible nitric oxide synthase expression in the brain during cerebral infection with Toxoplasma gondii in genetically resistant BALB/c mice but not in genetically susceptible C57BL/6 mice. Microbes Infect 24:104908. https://doi.org/10.1016/j.micinf.2021.104908. Divanovic S, Sawtell NM, Trompette A, Warning JI, Dias A et al (2012) Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis 205:152-61. https://doi.org/10.1093/infdis/jir621. Schwarcz R, Bruno JP, Muchowski PJ, Wu H-Q (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465-77. https://doi.org/10.1038/nrn3257. Kanova M, Kohout P (2021) Serotonin—Its Synthesis and Roles in the Healthy and the Critically Ill. Int J Mol Sci 22:4837. https://doi.org/10.3390/ijms22094837. Gonçalves S, Nunes-Costa D, Cardoso SM, Empadinhas N, Marugg JD (2022) Enzyme Promiscuity in Serotonin Biosynthesis, From Bacteria to Plants and Humans. Front Microbiol 13:873555. https://doi.org/10.3389/fmicb.2022.873555. Herr N, Bode C, Duerschmied D (2017) The Effects of Serotonin in Immune Cells. Front Cardiovasc Med 4:48. https://doi.org/10.3389/fcvm.2017.00048. Martin AM, Young RL, Leong L, Rogers GB, Spencer NJ, et al. The Diverse Metabolic Roles of Peripheral Serotonin. Endocrinology 158:1049-1063. https://doi.org/10.1210/en.2016-1839. Ito T, Ikeda U, Shimpo M, Yamamoto K, Shimada K (2000) Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells. Circulation 102:2522-2527. https://doi.org/10.1161/01.cir.102.20.2522. Nau Jr F, Yu B, Martin D, Nichols CD (2013) Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo. PloS one 8:e75426. https://doi.org/10.1371/journal.pone.0075426. Castello A, Bruschetta G, Giunta RP, Marino AMF, Ferlazzo AM (2018) The effect of Toxoplasma gondii on plasma serotonin concentration in sheep. Vet World 11:1500-1505. https://doi.org/10.14202/vetworld.2018.1500-1505. Pastre MJ, Casagrande L, Gois MB, Pereira-Severi LS, Miqueloto CA et al (2019) Toxoplasma gondii causes increased ICAM-1 and serotonin expression in the jejunum of rats 12 h after infection. Biomed Pharmacother 114:108797. https://doi.org/10.1016/j.biopha.2019.108797. Pastre MJ, Gois MB, Casagrande L, Pereira-Severi LS, de Lima LL et al (2021) Acute infection with Toxoplasma gondii oocysts preferentially activates non-neuronal cells expressing serotonin in the jejunum of rats. Life Sci 283:119872. https://doi.org/10.1016/j.lfs.2021.119872. Casagrande L, Pastre MJ, Trevizan AR, Cuman RKN, Bersani-Amado CA et al (2022) Moderate intestinal immunopathology after acute oral infection with Toxoplasma gondii oocysts is associated with expressive levels of serotonin. Life Sci 309:120985. https://doi.org/10.1016/j.lfs.2022.120985. Hermes G, Ajioka JW, Kelly KA, Mui E, Roberts F et al (2008) Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation 5:48. https://doi.org/10.1186/1742-2094-5-48. Cai G, Kastelein R, Hunter CA (2000) Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun 68:6932-6938. https://doi.org/10.1128/IAI.68.12.6932-6938.2000. Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y et al (2002) L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2, 3-dioxygenase. Infect Immun 70:779-786. https://doi.org/10.1128/IAI.70.2.779-786.2002. Ufermann C-M, Domröse A, Babel T, Tersteegen A, Cengiz SC et al (2019) Indoleamine 2, 3-dioxygenase activity during acute toxoplasmosis and the suppressed T cell proliferation in mice. Front Cell Infect Microbiol 9:184. https://doi.org/10.3389/fcimb.2019.00184. Donley DW, Olson AR, Raisbeck MF, Fox JH, Gigley JP (2016) Huntingtons disease mice infected with Toxoplasma gondii demonstrate early kynurenine pathway activation, altered CD8+ T-cell responses, and premature mortality. PloS one 11:e0162404. https://doi.org/10.1371/journal.pone.0162404. Munn DH, Mellor AL (2007) Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147-1154. https://doi.org/10.1172/JCI31178. Bauman N, Srbljanović J, Čolović Čalovski I, Lijeskić O, Ćirković V et al (2024) Structural Characterization of Toxoplasma gondii Brain Cysts in a Model of Reactivated Toxoplasmosis Using Computational Image Analysis. Fractal fract 8:175. Yao Y, Shi T, Shu P, Zhang Y, Gu H (2024) Toxoplasma gondii infection and brain inflammation: A two-sample mendelian randomization analysis. Heliyon 10:e24228. https://doi.org/10.1016/j.heliyon.2024.e24228. Wu H, Gong J, Liu Y (2018) Indoleamine 2, 3-dioxygenase regulation of immune response. Mol Med Rep 17:4867-4873. https://doi.org/10.3892/mmr.2018.8537. Additional Declarations No competing interests reported. Supplementary Files IDO1meltingcurve.docx Cite Share Download PDF Status: Published Journal Publication published 09 Feb, 2026 Read the published version in Acta Parasitologica → Version 1 posted Editorial decision: Revision requested 21 Aug, 2025 Editor assigned by journal 18 Aug, 2025 Submission checks completed at journal 18 Aug, 2025 First submitted to journal 17 Aug, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7390460","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":503812919,"identity":"2aef672d-7dc3-4c36-96c4-f77a90df289c","order_by":0,"name":"Elham Kordserkeche","email":"","orcid":"","institution":"Ahvaz Jundishapur University of Medical Sciences","correspondingAuthor":false,"prefix":"","firstName":"Elham","middleName":"","lastName":"Kordserkeche","suffix":""},{"id":503812920,"identity":"ccf3bfe8-64c8-42aa-9642-0fb4db72eac5","order_by":1,"name":"Jasem Saki","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA4klEQVRIiWNgGAWjYBACxgYoQ4KZ+QCIkiFFC1sCiOIh3joJBh4DEE1YC3P78YePbjDUyUu283x+daPGgoeB/fDRDXgd1pNjbJzDcNhwNjPvNuucY0CH8aSl3cCrpSGHTTqH4QDjPKAW4xw2oBYJHjP8WvqfP/+dw1BnP4+Z55lxzj9itMxIMGPOYWBOnM3Mw/w4t40oLW+MpXMMDifPbGYzY87tk+BhI+QXw/70h59zKupsZ5w//Phzzrc6OX72w8fwa2kAkeAYYWCTAJP4lIOAPBKb+QMh1aNgFIyCUTAyAQAOcUDMq+5bzQAAAABJRU5ErkJggg==","orcid":"","institution":"Ahvaz Jundishapur University of Medical Sciences","correspondingAuthor":true,"prefix":"","firstName":"Jasem","middleName":"","lastName":"Saki","suffix":""},{"id":503812921,"identity":"6fea6e82-c143-45f8-bedf-730c877b65a6","order_by":2,"name":"Reza arjmand","email":"","orcid":"","institution":"Ahvaz Jundishapur University of Medical Sciences","correspondingAuthor":false,"prefix":"","firstName":"Reza","middleName":"","lastName":"arjmand","suffix":""},{"id":503812922,"identity":"abaf00a0-80ca-41e6-a6d4-67565faf26eb","order_by":3,"name":"MohammadAmin Behmanesh","email":"","orcid":"","institution":"Dezful University of Medical Sciences","correspondingAuthor":false,"prefix":"","firstName":"MohammadAmin","middleName":"","lastName":"Behmanesh","suffix":""},{"id":503812923,"identity":"a8099768-ecae-46d7-a004-4fb04ee0657a","order_by":4,"name":"Saeedeh Shojaee","email":"","orcid":"","institution":"Tehran University of Medical Sciences","correspondingAuthor":false,"prefix":"","firstName":"Saeedeh","middleName":"","lastName":"Shojaee","suffix":""}],"badges":[],"createdAt":"2025-08-17 05:08:09","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7390460/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7390460/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1007/s11686-025-01213-w","type":"published","date":"2026-02-09T15:59:10+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":90335199,"identity":"82d6b4ed-670e-4d90-bf8a-6ef7407ce870","added_by":"auto","created_at":"2025-09-01 14:03:07","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":8235,"visible":true,"origin":"","legend":"\u003cp\u003eA 2.5% agarose gel used to analyze the qPCR products of IDO1 gene expression in cells infected with T. gondii type II strain during 60 days post infection. M: 50 bp molecular weight marker; lane 1: day 10; lane 2: day 20; lane 3: day 30; lanes 4: day 40; lane 5: day 50; lane 6: day60; lane 7: control (non-infected cells).\u003c/p\u003e","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7390460/v1/571852518b42afc8c8b20a32.jpg"},{"id":90334811,"identity":"45cb48c6-4d41-4868-8712-add89b551846","added_by":"auto","created_at":"2025-09-01 13:55:07","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":102620,"visible":true,"origin":"","legend":"\u003cp\u003eSerotonin serum levels in infected and non-Infected mice at different time points. Each data point represents the mean ± SD from six samples. P-values \u0026lt; 0.01 (**), P-values \u0026lt; 0.001 (***), P-values \u0026lt; 0.0001 (****) and P-values ns are regarded as non-significant.\u003c/p\u003e","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7390460/v1/b44d869f382485d40a53ed47.jpg"},{"id":90335200,"identity":"21a800f0-c1f6-43c3-93ac-5885a8ab638a","added_by":"auto","created_at":"2025-09-01 14:03:07","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":785925,"visible":true,"origin":"","legend":"\u003cp\u003eInduction of IDO1 mRNA expression in the brain following \u003cem\u003eT. gondii\u003c/em\u003e Infection in Balb/c mice. Total RNA was extracted from the brains of Balb/c mice at specified time points after intraperitoneal injection of \u003cem\u003eT. gondii\u003c/em\u003e and analyzed using real-time PCR. Each data point represents the mean ± SD from three to five samples.\u003c/p\u003e","description":"","filename":"Figure3.IDOmRNAexpressionfoldingchange.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7390460/v1/b98d662c07c06d2acef1dc5c.jpg"},{"id":90334815,"identity":"246d4b8b-c8ac-4f84-9358-ec47f843738d","added_by":"auto","created_at":"2025-09-01 13:55:07","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":210885,"visible":true,"origin":"","legend":"\u003cp\u003eRuptured tissue cyst in the brain of Balb/c mice 40-day post-infection.\u003c/p\u003e","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7390460/v1/09298cb846853edb6fd7c6b6.jpg"},{"id":102785903,"identity":"2a6af66a-17ad-4e97-8cb3-bf518668ed2b","added_by":"auto","created_at":"2026-02-16 16:10:57","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1857906,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7390460/v1/38b216a0-6467-466b-8b10-6caeadc59d0e.pdf"},{"id":90334814,"identity":"8c989d6e-33d4-4513-a326-75ed1d2a5bf7","added_by":"auto","created_at":"2025-09-01 13:55:07","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":298923,"visible":true,"origin":"","legend":"","description":"","filename":"IDO1meltingcurve.docx","url":"https://assets-eu.researchsquare.com/files/rs-7390460/v1/1a78bd0c45f37903cf237f0f.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Toxoplasma gondii: Effects on Serum Serotonin Concentration and Indoleamine 2, 3-Dioxygenase Expression","fulltext":[{"header":"1. Introduction","content":"\u003cp\u003eToxoplasma gondii (\u003cem\u003eT. gondii\u003c/em\u003e) is a highly successful intracellular protozoan parasite of the Apicomplexa phylum [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. Approximately one-third of the human population worldwide is estimated to be infected with \u003cem\u003eT. gondii\u003c/em\u003e [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e]. Felidaes, either wild or domestic ones, are considered as the ultimate hosts, while all warm-blooded, in particular, human are intermediate hosts, in which the asexual life cycle occurs [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. Humans can contract toxoplasmosis infection by consuming oocysts contaminated food, water, fruits, and vegetables; by ingesting tissue cysts in undercooked or raw meat; and by congenital transmission from mother to fetus during pregnancy [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]. Following the infection of \u003cem\u003eT. gondii\u003c/em\u003e in an intermediate host, sporozoites released from oocysts or bradyzoites inside tissue cysts infect enterocytes, transforming into rapidly reproducing tachyzoites that spread to many organs and tissues, resulting in an acute phase of infection. Tachyzoites transform into slowly replicating bradyzoites in reaction to the host immune system, forming cysts especially muscle and brain to develop a chronic infection. These bradyzoites develop cysts encased in a thick membrane that conceals them from the host's immune response. In final Felidae host, Bradyzoites within tissue cysts to invade enterocytes and differentiate into merozoites. Merozoites differentiate into male and female gametes, facilitating sexual reproduction and the subsequent excretion of many oocysts [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e]. \u003cem\u003eT.gondii\u003c/em\u003e infection is related to neurological and neurobehavioral disorders including Alzheimer\u0026rsquo;s disease, Parkinson's disease, depression, bipolar disorder, schizophrenia, and obsessive-compulsive disorder [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eIn the central nervous system (CNS), \u003cem\u003eT. gondii\u003c/em\u003e can breach the blood-brain barrier (BBB) and invade several parenchymal cells, such microglia, astrocytes, and neurons, which can contribute to the inflammatory response. \u003cem\u003eT. gondii\u003c/em\u003e infection may trigger alterations in the numbers of CD4\u003csup\u003e+\u003c/sup\u003e T cells and cytokines like Interferon-γ (IFN-γ). IFN-γ in CNS can stimulate astrocytes to generate chemokines that facilitate the entry of CD4\u003csup\u003e+\u003c/sup\u003e T cells into the CNS [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e]. This clarifies how T. gondii interacts with the BBB and immune response, leading to a complicated infection in the CNS.\u003c/p\u003e\u003cp\u003eIFNγ is most important cytokine in the host's anti-parasitic defense against \u003cem\u003eT. gondii\u003c/em\u003e [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. One of the ways that IFNγ exerts its anti-Toxoplasma effects is by stimulating the expression and activity of indoleamine 2,3-dioxygenase (IDO), which depletes L-tryptophan, an essential amino acid for the parasite's growth [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. IDO, an intracellular heme-containing enzyme, catalyzes the first and rate-limiting step in the breakdown of \u003csub\u003eL\u003c/sub\u003e-tryptophan in the kynurenine pathway [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. IDO exists in two forms: IDO1 and IDO2. All vertebrates possess both genes, with IDO1 found in all mammals, exhibiting a high affinity for \u003csub\u003eL\u003c/sub\u003e-tryptophan. IDO2 is present in both mammals and lower vertebrates but has a lower affinity for \u003csub\u003eL\u003c/sub\u003e-tryptophan, resulting in a reduced catalytic effect [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. In vitro experiments revealed that IDO inhibits \u003cem\u003eT. gondii\u003c/em\u003e growth in various mice and human cell lines [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e, \u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. A study showed that the administration of 1-methyltryptophan (1-MT), an IDO inhibitor, to mice in the chronic phases of \u003cem\u003eT. gondii\u003c/em\u003e infection led to increased death rates associated with rising parasite loads in the brain [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. Given that tryptophan is the precursor of serotonin, elevated IDO levels during \u003cem\u003eT. gondii\u003c/em\u003e infection might reduce production of serotonin [\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eSerotonin (5-hydroxytryptamine, 5-HT) is both a neurotransmitter and a peripheral hormone (16). In CNS it serves as a neurotransmitter that regulates important brain functions, including mood, sleep, cognition, memory, body temperature, and stress response [\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e]. Peripherally, 5-HT plays a significant role in major organ systems, regulating various processes such as hemostasis, organ development, cellular regeneration, gastrointestinal motility, immunology, cardiovascular and pulmonary physiology, and among others [\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e, \u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. Almost 95% of 5-HT is created by enterochromaffin cells in the gut, while the other 5% is mostly synthesized by serotonergic neurons in the central nervous system, with a smaller amount generated by adipose tissue, mammary glands, and pancreatic islets [\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e]. Most 5-HT in the body is circulated in the bloodstream, stored in platelets, and released upon platelet activation [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. 5-HT has significant effects on the immune system, although research on this topic has yielded conflicting results. Some studies suggest that serotonin has pro-inflammatory properties [\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e], while others indicate anti-inflammatory effects [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. It impacts various immune cells, stimulating the activation and proliferation of T lymphocytes, dendritic cells, neutrophils, B lymphocytes, and natural killer (NK) cells [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eThis study aims to evaluate IDO gene expression in brain cells and assess variations in serotonin levels in the blood of mice infected with \u003cem\u003eT. gondii\u003c/em\u003e at various time points post-infection. Previous studies have independently explored the impact of \u003cem\u003eToxoplasma gondii\u003c/em\u003e on IDO expression in the brain and serotonin levels in the blood. However, research simultaneously examining the effect of \u003cem\u003eToxoplasma gondii\u003c/em\u003e on IDO expression in brain cells and serotonin levels remains limited. This study was therefore designed to investigate the dual impact of \u003cem\u003eToxoplasma gondii\u003c/em\u003e on IDO gene expression in brain cells and serum serotonin levels over a 60-day period with measurements taken at 10-day intervals.\u003c/p\u003e"},{"header":"2. Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e\u003ch2\u003e2.1. Animals\u003c/h2\u003e\u003cp\u003eThe study involved 84 female Balb/c mice, each weighing approximately 200 grams and aged 5 weeks. Mice were bought from the animal house of Jondishapour Medical Sciences University of Ahvaz (Iran, Ahvaz) and care in specific pathogen-free conditions. The mice were divided into two groups: 42 in the experimental group and 42 in the control group. Each group was further subdivided into six subgroups of seven mice each. The animals were housed in polypropylene cages, with 4 to 5 mice per cage, and had unrestricted access to food and water. The experimental group received an intraperitoneal injection of \u003cem\u003eT.gondii\u003c/em\u003e bradyzoites, while the control group was injected with phosphate-buffered saline (PBS). All procedures performed on animals in this study was approved by the Animal Care and Use Committee of Ahvaz Jundishapur University of Medical Sciences (IR.AJUMS.ABHC.REC.1401.021) and adhered to National Institutes of Health guidelines.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec4\" class=\"Section2\"\u003e\u003ch2\u003e2.2. Inoculation of Cyst-free \u003cem\u003eT. gondii\u003c/em\u003e Parasites\u003c/h2\u003e\u003cp\u003e\u003cem\u003eT.gondii\u003c/em\u003e Type II was isolated from young C57BL/6 mice infected via oral gavage with 10 cysts and sacrificed 4 to 5 weeks post-infection. Cyst-free parasites were prepared following established protocols. Briefly, fresh brain tissue was homogenized in 2 ml of sterile PBS using a Dounce homogenizer for one minute on ice. The homogenate was centrifuged at 2000 x g for 5 minutes at 4\u0026deg;C, and the supernatant was discarded. The pellet was resuspended in 20 ml of sterile 30% Percoll and centrifuged for 20 minutes at 2000 x g at 15\u0026deg;C with no brake. After discarding the supernatant, the pellet was treated with 100 \u0026micro;l of 0.25% (v/v) trypsin for 30 seconds, then diluted with 900 \u0026micro;l of PBS. This mixture was added to 4 ml of PBS and filtered through a 3 \u0026micro;m filter. Parasite concentration was determined using a hemocytometer, and each mouse received 100 parasites (0.2 ml) via intraperitoneal (IP) injection.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec5\" class=\"Section2\"\u003e\u003ch2\u003e2.3. Sample Collection\u003c/h2\u003e\u003cp\u003eMice from each group were anesthetized with ketamine (30\u0026ndash;50 mg/kg) administered IP injection every 10 days, and blood and brain samples were collected. Blood samples were obtained from tail vein and put to clot activator tubes. Plasma samples were collected after centrifugation at 3000 rpm for 15 minutes at 4\u0026deg;C and stored at -80\u0026deg;C. Brains were collected and washed in sterile ice-cold PBS. The tissue samples were immediately frozen in liquid nitrogen using a tissue-freezing medium (Leica Biosystems, USA) for further analysis.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec6\" class=\"Section2\"\u003e\u003ch2\u003e2.4. Determination of Anti-\u003cem\u003eT. gondii\u003c/em\u003e Antibodies\u003c/h2\u003e\u003cp\u003eThe presence of anti-\u003cem\u003eT. gondii\u003c/em\u003e antibodies was assessed 10 days post-inoculation using a Mouse Toxoplasmosis (TOXO) Antibody (IgG) ELISA Kit (Novus Biologicals, USA). Optical densities (ODs) were measured at λ\u0026thinsp;=\u0026thinsp;450 nm on two wells per sample using a BioTek SP2 microplate reader (USA).\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec7\" class=\"Section2\"\u003e\u003ch2\u003e2.5. Histopathological Studies\u003c/h2\u003e\u003cp\u003eBrain tissues were fixed in 10% formalin solution, then embedded in paraffin, and sectioned to a thickness of 5\u0026ndash;7 \u0026micro;m. Serial sagittal sections were stained with hematoxylin and eosin (H\u0026amp;E).\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec8\" class=\"Section2\"\u003e\u003ch2\u003e2.6. Analysis of Serum 5-HT Concentration\u003c/h2\u003e\u003cp\u003eSerum 5-HT levels were quantified using BioVision's Serotonin ELISA Kit (Milpitas Blvd., Milpitas, CA 95035, USA), a competitive ELISA assay. Standards were processed according to the reference protocol for each assay. OD values for the standards were used to create a semi-logarithmic reference curve, allowing the 5-HT content of each serum sample to be extrapolated from its corresponding OD value.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec9\" class=\"Section2\"\u003e\u003ch2\u003e2.7. Gene expression analysis\u003c/h2\u003e\u003cp\u003eThe mRNA levels of IDO were assessed by quantitative real-time polymerase chain reaction (qRT\u0026ndash;PCR) (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e). Total RNA was isolated from the cerebral cortex and striatum using an RNeasy Mini Kit (Qiagen, Germany) according to mentioned protocol. The concentration of extracted RNAs was quantified utilizing a NanoDrop spectrophotometer (Thermo Scientific NanoDrop). Reverse transcription of 1 \u0026micro;g of total RNA to complementary DNA (cDNA) was carried out employing the ExcelRT\u0026trade; Reverse Transcription Kit (SMOBIO, Taiwan) in accordance with the manufacturer's instructions. The qRT-PCR was run with the TaKaRa PCR Amplification Kit (Takara Bio Inc., Japan) and primers and carried out on a StepOne\u003csup\u003ePlus\u003c/sup\u003e Real-Time PCR system (Applied Biosystems, Branchburg, New Jersey). Each PCR reaction (20 \u0026micro;l) contained 1 \u0026micro;l of cDNA, 6.25 \u0026micro;l of QPCR Master Mix SYBR Green, 0.25 \u0026micro;l of each primer, and 4.75 \u0026micro;l of distilled water. The PCR cycles consisted of an initial 5 minutes at 95\u0026deg;C, followed by 40 cycles of 15 seconds at 95\u0026deg;C, 20 seconds at 60\u0026deg;C, and 20 seconds at 72\u0026deg;C. Gene expression was normalized to the GAPDH, a housekeeping gene. Gene expression levels were calculated using the 2\u003csup\u003e\u0026minus;ΔΔCt\u003c/sup\u003e method. The specific primer sequences were as follows:\u003c/p\u003e\u003cp\u003e\u003c/p\u003e\u003cp\u003e- \u003cem\u003eIDO1\u003c/em\u003e\u003c/p\u003e\u003cp\u003eForward: 5\u0026rsquo;-CCTTCTGGGAATAAAACACGAGG-3\u0026rsquo;\u003c/p\u003e\u003cp\u003eReverse: 5\u0026rsquo;-CTAAGAAGA AAAGGAAGTTCCGG-3\u0026rsquo;\u003c/p\u003e\u003cp\u003e- \u003cem\u003eIDO2\u003c/em\u003e\u003c/p\u003e\u003cp\u003eForward: 5\u0026rsquo;-ATCTCCACGTAGCTCCTTCT-3\u0026rsquo;\u003c/p\u003e\u003cp\u003eReverse: 5\u0026rsquo;-GCCTCCACACACTGGTTATAG-3\u0026rsquo;\u003c/p\u003e\u003cp\u003e- \u003cem\u003eGAPDH\u003c/em\u003e\u003c/p\u003e\u003cp\u003eForward: 5\u0026rsquo;-GGTCACCAGGGCTGCTTTTA-3\u0026rsquo;\u003c/p\u003e\u003cp\u003eReverse: 3\u0026rsquo; -CCGTTCTCAGCCATGTAGT- 5\u0026rsquo;\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec10\" class=\"Section2\"\u003e\u003ch2\u003e2.8. Statistical Analysis\u003c/h2\u003e\u003cp\u003eThe levels of serotonin and \u003cem\u003eIDO1\u003c/em\u003e mRNA gene expression folding changes were reported as mean\u0026thinsp;\u0026plusmn;\u0026thinsp;standard deviation (SD) and Data were measured in triplicate. The 2\u003csup\u003e\u0026ndash;ΔΔCt\u003c/sup\u003e method was also implemented to calculate the \u003cem\u003eIDO1\u003c/em\u003e mRNA gene expression folding changes Student t-test and two-way ANOVA tests were employed for comparison between unpaired and within the study groups, respectively. P-values less than 0.05 were considered as significant level. P-values\u0026thinsp;\u0026lt;\u0026thinsp;0.05 (*), P-values\u0026thinsp;\u0026lt;\u0026thinsp;0.01 (**), P-values\u0026thinsp;\u0026lt;\u0026thinsp;0.001 (***) and P-values\u0026thinsp;\u0026lt;\u0026thinsp;0.0001 (****). All calculations were performed using the GraphPad Prism software (GraphPad Software Inc., San Diego, CA, USA).\u003c/p\u003e\u003c/div\u003e"},{"header":"3. Results","content":"\u003cp\u003e\u003cb\u003e3.1. Temporal Profiles of IDO Induction and 5-HT Concentration Alteration in Balb/c Mice Infected with\u003c/b\u003e \u003cb\u003eT. gondii\u003c/b\u003e\u003c/p\u003e\u003cp\u003eWe assessed the time course of changes in the serum levels of serotonin and \u003cem\u003eIDO1\u003c/em\u003e mRNA expression in the brains of Balb/c mice infected with \u003cem\u003eT. gondii\u003c/em\u003e. It is observed that the serotonin serum concentration in the infected Balb/c mice was substantially higher than the non-infected groups on the day 10th, 20th, 30th and 40th post-infection, while the serotonin serum was dramatically diminished in the infected groups rather than non-infected mice on day 60th. Serotonin serum levels in the infected and non-Infected mice at different time points are depicted in Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e.\u003c/p\u003e\u003cp\u003e\u003c/p\u003e\u003cp\u003eThe mRNA levels of the two IDO isoforms (\u003cem\u003eIDO1\u003c/em\u003e and \u003cem\u003eIDO2\u003c/em\u003e) were assessed in these mice. Notably, the expression of the \u003cem\u003eIDO1\u003c/em\u003e gene in brain cells increased by 5.65-fold on day 10 post-infection, followed by a slight decrease until day 30th. On day 40th, a drastic reduction of 1.91-fold was observed, but an increase of 4.8-fold taken place on day 50th. However, by day 60th, a considerable attenuation of 1.29-fold occurred (Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003e). Notably, no mRNA expression of IDO2 was detected.\u003c/p\u003e\u003cp\u003e\u003c/p\u003e\u003cdiv id=\"Sec12\" class=\"Section2\"\u003e\u003ch2\u003e3.2. Pathological Results\u003c/h2\u003e\u003cp\u003eTwenty-day post-infection, tissue cysts were detected in the brains of Balb/c mice. By day 40th, some mice exhibited ruptured tissue cysts (Fig.\u0026nbsp;\u003cspan refid=\"Fig4\" class=\"InternalRef\"\u003e4\u003c/span\u003e). In contrast, no cysts were observed in any mice from the control group.\u003c/p\u003e\u003cp\u003e\u003c/p\u003e\u003c/div\u003e"},{"header":"4. Discussion","content":"\u003cp\u003eThe findings of this study revealed that not only there is a significant increase in the serotonin serum concentration in the \u003cem\u003eT.gondii\u003c/em\u003e infected mice group by the 40th day post-infection compared to the control group but also the \u003cem\u003eIDO1\u003c/em\u003e mRNA expression folding change was noticeable in the brain of Balb/c infected mice pertinent to the control group. The surge in serotonin may be linked to the activation of platelets, known to store serotonin and release it upon activation. The initial boost in serotonin levels suggests that the immune response to tachyzoites in the bloodstream may be intense during this stage, as platelets play an essential role in immune defense and inflammation. On the 10th day after infection, tachyzoites increased the concentration of serum serotonin by entering the blood and probably by the induction of platelets, which are the storage source of serotonin, and during that period of time, a part of tachyzoites probably went to the brain and interacted with cells. Cerebral induction caused the expression of IDO1. The increase in the expression of this gene was accompanied by a decrease in serum serotonin levels on the 20th and 30th days. On the 20th and 30th days, the expression of IDO 1 decreased, and on the 40th day, we observed the amplification in the concentration of serum serotonin levels, which was associated with a more decrease in \u003cem\u003eIDO1\u003c/em\u003e gene in this period. Continuing to measure serum serotonin and \u003cem\u003eIDO1\u003c/em\u003e gene expression in the brain showed that on the 50th day, the level of serum serotonin decreased and the expression of the \u003cem\u003eIDO1\u003c/em\u003e gene increased. By examining the pathology of the brain tissue, we observed that tissue cysts were ruptured on the 40th day, and this is probably the cause and this was probably the reason for the \u003cem\u003eIDO1\u003c/em\u003e gene expression to be reactivated and show a significant increase after 10 days of measurement, on the 50th day. After that and on the 60th day, the measurements of the two mentioned parameters showed that they both decreased on the 60th day. This finding aligns with numerous studies investigating the effects of \u003cem\u003eT.gondii\u003c/em\u003e on blood serotonin levels and related gene expression. For instance, research by Castello et al. demonstrated that serotonin levels in the blood of 17 sheep with anti-\u003cem\u003eToxoplasma\u003c/em\u003e antibodies were significantly higher than in the control group, with infected sheep exhibiting greater platelet and monocyte counts [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. Similarly, Pastre et al. reported elevated expression of the 5-HT, ICAM1, Type II collagen, and total mast cell genes in rats infected with sporulated oocysts of \u003cem\u003eT. gondii\u003c/em\u003e [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]. This study somehow highlighted a strong correlation between mast cell migration to the infection site and increased expression of ICAM1 and 5-HT during peak infection.\u003c/p\u003e\u003cp\u003eIn another study, Pastre \u003cem\u003eet al.\u003c/em\u003e found that acute infection with \u003cem\u003eT. gondii\u003c/em\u003e oocysts in mice preferentially activates non-neuronal cells to secrete serotonin [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e]. Their findings suggested that \u003cem\u003eT. gondii\u003c/em\u003e manipulates the jejunal epithelium to activate the immune system, including mast cells. An increase in enterochromaffin cells and mast cells expressing serotonin was also noted in the jejunum wall. According to Casagrande et al., serotonin expression levels are associated with moderate intestinal immunomodulation following acute infection with \u003cem\u003eT. gondii\u003c/em\u003e oocysts in C57BL/6 mice [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e]. Mucus from infected mice showed a marked increase in serotonin-immunoreactive cells.\u003c/p\u003e\u003cp\u003eStrikingly, \u003cem\u003eT. gondii\u003c/em\u003e multiplies as a tachyzoite within nucleated cells after entering the host. Once the immune response is overcome, it transforms into an inactive bradyzoite, forming tissue cysts in various organs, primarily the brain, where they can remain dormant [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]. In response to infection, macrophages produce the cytokine IL-12, which prompts natural killer cells to produce interferon gamma (IFN-γ) [\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e]. IFN-γ inhibits the intracellular proliferation of the parasite in human and mouse cells, with mice lacking IFN-γ being unable to control \u003cem\u003eT. gondii\u003c/em\u003e growth. Various studies have demonstrated that IFN-γ exerts anti-\u003cem\u003eT. gondii\u003c/em\u003e effects in human cells, such as macrophages, fibroblasts, and microglial cells, by inducing indoleamine 2,3-dioxygenase (IDO). IDO is expressed in microglial cells in the brain and is responsible for tryptophan degradation, serving as a defense mechanism against \u003cem\u003eT. gondii\u003c/em\u003e [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eIn current study throughout the 60-day period, complex interactions between the parasite and host responses were observed. In the acute phase of toxoplasmosis, \u003cem\u003eIDO1\u003c/em\u003e expression appears to be stimulated, while its levels decline when \u003cem\u003eT. gondii\u003c/em\u003e enters the chronic phase. Ufermann et al. reported a definite induction of \u003cem\u003eIDO1\u003c/em\u003e during acute murine toxoplasmosis in their experimental model [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]. Other studies have also demonstrated \u003cem\u003eIDO1\u003c/em\u003e expression in mice infected with \u003cem\u003eT. gondii\u003c/em\u003e, with IDO activation leading to increased and earlier mortality in Huntington disease mice [\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e]. Fujigak et al. found significantly higher levels of IDO enzyme activity and IDO mRNA in the brains and lungs of C57BL/6 mice compared to those lacking IFN-γ [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. Their findings suggest that inducible nitric oxide synthase (iNOS) and IDO are cross-regulated in an anti-\u003cem\u003eT. gondii\u003c/em\u003e manner.\u003c/p\u003e\u003cp\u003eIn this study, we observed a significant increase in \u003cem\u003eIDO1\u003c/em\u003e gene expression shortly after infection, followed by fluctuations over the subsequent 10-day intervals. This pattern suggests that the initial entry of \u003cem\u003eT. gondii\u003c/em\u003e tachyzoites into the brain triggers an immune response, activating the kynurenine pathway. The upregulation of the IDO1 enzyme appears to be a strategy to deprive the parasite of tryptophan, an amino acid essential for parasite growth [\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e]. IDO1 has been shown to play a significant role in immune regulation during infection, as its upregulation can lead to tryptophan catabolism, thus limiting the parasite's availability of this critical resource. The decline in gene expression on days 20th, 30th, and 40th likely corresponds to the parasite transitioning into its chronic and inactive phase. The increase in expression on day 50th suggests reactivation of the parasite, overcoming the host's immune defenses, which can often occur after a period of dormancy or immune evasion [\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e] .\u003c/p\u003e\u003cp\u003eExamination of the brains of infected mice revealed ruptured cysts on day 40th, indicating parasite reactivation, which was associated with increased \u003cem\u003eIDO1\u003c/em\u003e expression that subsequently decreased again after 10 days [\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e]. This temporal pattern of IDO1 regulation has been linked to the host's immune response and parasite reactivation dynamics [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eThis timeline demonstrates how \u003cem\u003eToxoplasma gondii\u003c/em\u003e infection influences host biochemistry, particularly serotonin levels, through an immune-mediated mechanism involving IDO1. These fluctuations in serotonin, driven by immune responses and parasite behavior, could have significant physiological and neurological consequences. For instance, as serotonin is a key neurotransmitter involved in mood regulation, its depletion during infection phases might explain behavioral changes in infected hosts. Additionally, the study provides profound insights into how the immune response adapts from an acute phase, characterized by high serotonin turnover and IDO1 activation, to a chronic phase where the immune response stabilizes as tissue cysts form.\u003c/p\u003e\u003cp\u003eSimilar to other studies, this study includes some strength and limitation points. The current study is the first one, within which we checked the serotonin concentration and relative expression of \u003cem\u003eIDO1\u003c/em\u003e in \u003cem\u003eT.gondii\u003c/em\u003e infected Balb/c mice by day 60 post-infection, which can take into account as a novelty of this investigation. However, some limitations and suggestions are observed as follows: 1) the measurement of inflammatory cytokines, particularly IFN-γ in the blood and brain, could not be conducted; 2) Regarding the IDO can impact on anti-inflammatory cytokines secretion such as tumor growth factor beta and interleukin 10, the assessment of these cytokine fluctuations in the blood and brain of the infected mice during the post-infection period may have a beneficiary for evaluation and modulation of inflammatory response. 3) Given that regulatory T cells occupy a prominent role in IDO secretion, the evaluation of this immune cell subset frequency can be fruitful in this context.\u003c/p\u003e"},{"header":"5. Conclusion","content":"\u003cp\u003eOverall, this infection timeline reflects the complex interactions between a pathogen and host defenses, affecting both the brain and systemic biochemistry. It is revealed that the serum level of serotonin and IDO1 mRNA expression were significantly higher in \u003cem\u003eT.gondii\u003c/em\u003e infected Balb/c mice than normal control group. However, future investigations could explore therapeutic interventions targeting IDO1 or serotonin pathways to mitigate neurological impacts in chronic \u003cem\u003eT.gondii\u003c/em\u003e infections.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eEthics statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;The Animal Care and Use Committee of Ahvaz Jundishapur University of Medical Sciences (IR.AJUMS.ABHC.REC.1401.021) approved this study and all procedures used for animal experiments.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;All authors participated to the research described in this study.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for publication\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAll authors gave their consent for the research described in this study to be published.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCRediT authorship contribution statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eElham Kordserkeche:\u003c/strong\u003e Conducting experiments, writing \u0026ndash; review \u0026amp; editing, writing original draft; \u003cstrong\u003eJasem Saki:\u003c/strong\u003e Conceptualization; \u003cstrong\u003eReza Arjmand:\u003c/strong\u003e Data curation; \u003cstrong\u003eMohammad Amin Behmanesh:\u003c/strong\u003e Methodology; \u003cstrong\u003eSaeedeh Shojaee:\u003c/strong\u003e Methodology.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDeclaration of competing interest\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNone.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis research was supported by Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (grant number: CMRC-0106).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData availability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003eThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgments\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study originates from the thesis of a Ph.D. student, Elham Kordserkeche, granted by Ahvaz Jundishapur University of Medical Sciences (CMRC-0106). We feel it necessary to express our sincere gratitude to Dr. Tabandeh from Shahid Chamran Ahvaz University for his valuable assistance.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransparency Statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe corresponding author, Dr. Jasem Saki approve that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been discarded; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eMontazeri M, Mehrzadi S, Sharif M, Sarvi S, Tanzifi A et al (2018) Drug Resistance in Toxoplasma gondii. Front Microbiol\u003cem\u003e \u003c/em\u003e9:2587. https://doi.org/10.3389/fmicb.2018.02587.\u003c/li\u003e\n\u003cli\u003eDubey JP (2009) History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol 39:877-882. https://doi.org/10.1016/j.ijpara.2009.01.005.\u003c/li\u003e\n\u003cli\u003eAfonso C, Paix\u0026atilde;o VB, Klaus A, Lunghi M, Piro F et al (2017) Toxoplasma-induced changes in host risk behaviour are independent of parasite-derived AaaH2 tyrosine hydroxylase\u003cem\u003e \u003c/em\u003eSci Rep 7:13822. https://doi.org/10.1038/s41598-017-13229-y.\u003c/li\u003e\n\u003cli\u003eNasiru Wana M, Mohd Moklas MA, Watanabe M, Nordin N, Zasmy Unyah N et al (2020) A Review on the Prevalence of Toxoplasma gondii in Humans and Animals Reported in Malaysia from 2008\u0026ndash;2018. Int J Environ Res Public Health 17:4809. https://doi.org/10.3390/ijerph17134809.\u003c/li\u003e\n\u003cli\u003eSharma J, Rodriguez P, Roy P, Guiton PS (2020) Transcriptional ups and downs: patterns of gene expression in the life cycle of Toxoplasma gondii. Microbes Infect 22:525-533. https://doi.org/ 10.1016/j.micinf.2020.09.001.\u003c/li\u003e\n\u003cli\u003eVirus MA, Ehrhorn EG, Lui LM, Davis PH (2021) Neurological and Neurobehavioral Disorders Associated with Toxoplasma gondii Infection in Humans. J Parasitol Res 2021:6634807. https://doi.org/10.1155/2021/6634807.\u003c/li\u003e\n\u003cli\u003eWang Q, Zhong Y, Chen N, Chen J (2023) From the immune system to mood disorders especially induced by Toxoplasma gondii: CD4+ T cell as a bridge. Front Cell Infect Microbiol 13:1078984. https://doi.org/10.3389/fcimb.2023.1078984.\u003c/li\u003e\n\u003cli\u003eHunt NH, Too LK, Khaw LT, Guo J, Hee L et al (2017) The kynurenine pathway and parasitic infections that affect CNS function. Neuropharmacology 112:389-398. https://doi.org/10.1016/j.neuropharm.2016.02.029.\u003c/li\u003e\n\u003cli\u003eTedford E, McConkey G (2017) Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection. Pathogens 6:19. https://doi.org/10.3390/pathogens6020019.\u003c/li\u003e\n\u003cli\u003eBello C, Heinisch PP, Mihalj M, Carrel T, Luedi MM (2021) Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System.\u003cem\u003e \u003c/em\u003eFront Physiol 12:766511. https://doi.org/10.3389/fphys.2021.766511.\u003c/li\u003e\n\u003cli\u003eYuasa HJ, Ball HJ, Ho YF, Austin CJ, Whittington CM et al (2009) Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases: IDOs from monotremes and marsupials. Comp Biochem Physiol B Biochem Mol Biol 153:137-44.\u003c/li\u003e\n\u003cli\u003eSchmidt SK, Ebel S, Keil E, Woite C, Ernst JF et al (2013) Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions. PLoS One 8:e63301. https://doi.org/10.1371/journal.pone.0063301.\u003c/li\u003e\n\u003cli\u003eAnand N, Lutshumba J, Whitlow M, Abdelaziz MH, Mani R, Suzuki Y (2022) Deficiency in indoleamine-2, 3-dioxygenase induces upregulation of guanylate binding protein 1 and inducible nitric oxide synthase expression in the brain during cerebral infection with Toxoplasma gondii in genetically resistant BALB/c mice but not in genetically susceptible C57BL/6 mice. Microbes Infect 24:104908. https://doi.org/10.1016/j.micinf.2021.104908.\u003c/li\u003e\n\u003cli\u003eDivanovic S, Sawtell NM, Trompette A, Warning JI, Dias A et al (2012) Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis 205:152-61. https://doi.org/10.1093/infdis/jir621.\u003c/li\u003e\n\u003cli\u003eSchwarcz R, Bruno JP, Muchowski PJ, Wu H-Q (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465-77. https://doi.org/10.1038/nrn3257.\u003c/li\u003e\n\u003cli\u003eKanova M, Kohout P (2021) Serotonin\u0026mdash;Its Synthesis and Roles in the Healthy and the Critically Ill. Int J Mol Sci 22:4837. https://doi.org/10.3390/ijms22094837.\u003c/li\u003e\n\u003cli\u003eGon\u0026ccedil;alves S, Nunes-Costa D, Cardoso SM, Empadinhas N, Marugg JD (2022) Enzyme Promiscuity in Serotonin Biosynthesis, From Bacteria to Plants and Humans. Front Microbiol 13:873555. https://doi.org/10.3389/fmicb.2022.873555.\u003c/li\u003e\n\u003cli\u003eHerr N, Bode C, Duerschmied D (2017) The Effects of Serotonin in Immune Cells. Front Cardiovasc Med\u003cem\u003e \u003c/em\u003e4:48. https://doi.org/10.3389/fcvm.2017.00048.\u003c/li\u003e\n\u003cli\u003eMartin AM, Young RL, Leong L, Rogers GB, Spencer NJ, et al. The Diverse Metabolic Roles of Peripheral Serotonin. Endocrinology 158:1049-1063. https://doi.org/10.1210/en.2016-1839.\u003c/li\u003e\n\u003cli\u003eIto T, Ikeda U, Shimpo M, Yamamoto K, Shimada K (2000) Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells. Circulation 102:2522-2527. https://doi.org/10.1161/01.cir.102.20.2522.\u003c/li\u003e\n\u003cli\u003eNau Jr F, Yu B, Martin D, Nichols CD (2013) Serotonin 5-HT2A receptor activation blocks TNF-\u0026alpha; mediated inflammation in vivo. PloS one 8:e75426. https://doi.org/10.1371/journal.pone.0075426.\u003c/li\u003e\n\u003cli\u003eCastello A, Bruschetta G, Giunta RP, Marino AMF, Ferlazzo AM (2018) The effect of Toxoplasma gondii on plasma serotonin concentration in sheep. Vet World 11:1500-1505. https://doi.org/10.14202/vetworld.2018.1500-1505.\u003c/li\u003e\n\u003cli\u003ePastre MJ, Casagrande L, Gois MB, Pereira-Severi LS, Miqueloto CA et al (2019) Toxoplasma gondii causes increased ICAM-1 and serotonin expression in the jejunum of rats 12 h after infection. Biomed Pharmacother 114:108797. https://doi.org/10.1016/j.biopha.2019.108797.\u003c/li\u003e\n\u003cli\u003ePastre MJ, Gois MB, Casagrande L, Pereira-Severi LS, de Lima LL et al (2021) Acute infection with Toxoplasma gondii oocysts preferentially activates non-neuronal cells expressing serotonin in the jejunum of rats. Life Sci 283:119872. https://doi.org/10.1016/j.lfs.2021.119872.\u003c/li\u003e\n\u003cli\u003eCasagrande L, Pastre MJ, Trevizan AR, Cuman RKN, Bersani-Amado CA et al (2022) Moderate intestinal immunopathology after acute oral infection with Toxoplasma gondii oocysts is associated with expressive levels of serotonin. Life Sci 309:120985. https://doi.org/10.1016/j.lfs.2022.120985.\u003c/li\u003e\n\u003cli\u003eHermes G, Ajioka JW, Kelly KA, Mui E, Roberts F et al (2008) Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation 5:48. https://doi.org/10.1186/1742-2094-5-48.\u003c/li\u003e\n\u003cli\u003eCai G, Kastelein R, Hunter CA (2000) Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun 68:6932-6938. https://doi.org/10.1128/IAI.68.12.6932-6938.2000.\u003c/li\u003e\n\u003cli\u003eFujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y et al (2002) L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2, 3-dioxygenase. Infect Immun 70:779-786. https://doi.org/10.1128/IAI.70.2.779-786.2002.\u003c/li\u003e\n\u003cli\u003eUfermann C-M, Domr\u0026ouml;se A, Babel T, Tersteegen A, Cengiz SC et al (2019) Indoleamine 2, 3-dioxygenase activity during acute toxoplasmosis and the suppressed T cell proliferation in mice. Front Cell Infect Microbiol 9:184. https://doi.org/10.3389/fcimb.2019.00184.\u003c/li\u003e\n\u003cli\u003eDonley DW, Olson AR, Raisbeck MF, Fox JH, Gigley JP (2016) Huntingtons disease mice infected with Toxoplasma gondii demonstrate early kynurenine pathway activation, altered CD8+ T-cell responses, and premature mortality. PloS one 11:e0162404. https://doi.org/10.1371/journal.pone.0162404.\u003c/li\u003e\n\u003cli\u003eMunn DH, Mellor AL (2007) Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147-1154. https://doi.org/10.1172/JCI31178.\u003c/li\u003e\n\u003cli\u003eBauman N, Srbljanović J, Čolović Čalovski I, Lijeskić O, Ćirković V et al (2024) Structural Characterization of Toxoplasma gondii Brain Cysts in a Model of Reactivated Toxoplasmosis Using Computational Image Analysis. Fractal fract 8:175.\u003c/li\u003e\n\u003cli\u003eYao Y, Shi T, Shu P, Zhang Y, Gu H (2024) Toxoplasma gondii infection and brain inflammation: A two-sample mendelian randomization analysis.\u003cem\u003e \u003c/em\u003eHeliyon 10:e24228. https://doi.org/10.1016/j.heliyon.2024.e24228.\u003c/li\u003e\n\u003cli\u003eWu H, Gong J, Liu Y (2018) Indoleamine 2, 3-dioxygenase regulation of immune response. Mol Med Rep 17:4867-4873. https://doi.org/10.3892/mmr.2018.8537.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"acta-parasitologica","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"actp","sideBox":"Learn more about [Acta Parasitologica](http://link.springer.com/journal/11686)","snPcode":"11686","submissionUrl":"https://submission.springernature.com/new-submission/11686/3","title":"Acta Parasitologica","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Serum, Serotonin, Indoleamine 2, 3-dioxygenase, Brain, Toxoplasma gondii","lastPublishedDoi":"10.21203/rs.3.rs-7390460/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7390460/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eBackground\u003c/h2\u003e\u003cp\u003e\u003cem\u003eToxoplasma gondii\u003c/em\u003e is an obligate intracellular protozoan that infects approximately one-third of the global population. Research has increasingly suggested a connection between toxoplasmosis and alterations in behavior. This study aims to investigate the effects of \u003cem\u003eT. gondii\u003c/em\u003e infection on serum serotonin levels and the expression of the indoleamine 2, 3-dioxygenase (IDO) gene in the brain cells of Balb/c mice.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e\u003cp\u003eA total of 72 female Balb/c mice were utilized in this study, with 36 assigned to the experimental group and 36 to the control group. The mice were further divided into six subgroups, each containing six mice. Serum serotonin levels were quantified using the ELISA method, while the expression of the \u003cem\u003eIDO1\u003c/em\u003e gene was assessed through quantitative real-time PCR.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e\u003cp\u003eIt is observed that the serotonin serum concentration in the infected Balb/c mice was substantially higher than the non-infected groups on the day 10th (371.17\u0026thinsp;\u0026plusmn;\u0026thinsp;53.391 vs. 233.50\u0026thinsp;\u0026plusmn;\u0026thinsp;1.225, p\u0026thinsp;\u0026lt;\u0026thinsp;0.0001), 20th (283.33\u0026thinsp;\u0026plusmn;\u0026thinsp;41.707 vs. 233.33\u0026thinsp;\u0026plusmn;\u0026thinsp;1.033, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05 ), 30th (269.17\u0026thinsp;\u0026plusmn;\u0026thinsp;36.766 vs. 233.67\u0026thinsp;\u0026plusmn;\u0026thinsp;0.516, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05) and 40th (291.50\u0026thinsp;\u0026plusmn;\u0026thinsp;62.956 vs. 233.67\u0026thinsp;\u0026plusmn;\u0026thinsp;1.033, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05) post-infection, while the serotonin serum was dramatically diminished in the infected groups rather than the control mice on day 60th (197.50\u0026thinsp;\u0026plusmn;\u0026thinsp;23.998 vs. 233.17\u0026thinsp;\u0026plusmn;\u0026thinsp;1.472, p\u0026thinsp;\u0026lt;\u0026thinsp;0.01). Notably, the expression of the \u003cem\u003eIDO1\u003c/em\u003e gene in brain cells increased by 5.65-fold on day 10 post-infection, followed by downward trends by day 40th (1.91-fold) was observed. Moreover, sharp fluctuations also took place on the 50th and 60th .\u003c/p\u003e\u003ch2\u003eConclusion\u003c/h2\u003e\u003cp\u003eIt is conclusively revealed that the serum level of serotonin and \u003cem\u003eIDO1\u003c/em\u003e mRNA expression were significantly higher in \u003cem\u003eT.gondii\u003c/em\u003e infected Balb/c mice than normal control group. However, future investigations could explore therapeutic interventions targeting IDO1 or serotonin pathways to mitigate neurological impacts in chronic \u003cem\u003eT.gondii\u003c/em\u003e infections.\u003c/p\u003e","manuscriptTitle":"Toxoplasma gondii: Effects on Serum Serotonin Concentration and Indoleamine 2, 3-Dioxygenase Expression","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-09-01 13:55:02","doi":"10.21203/rs.3.rs-7390460/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2025-08-21T17:24:51+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-08-18T14:53:17+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-08-18T14:52:13+00:00","index":"","fulltext":""},{"type":"submitted","content":"Acta Parasitologica","date":"2025-08-17T04:57:56+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"acta-parasitologica","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"actp","sideBox":"Learn more about [Acta Parasitologica](http://link.springer.com/journal/11686)","snPcode":"11686","submissionUrl":"https://submission.springernature.com/new-submission/11686/3","title":"Acta Parasitologica","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"930e9270-19c0-4b7e-a303-0901d3c66fa8","owner":[],"postedDate":"September 1st, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2026-02-16T16:08:52+00:00","versionOfRecord":{"articleIdentity":"rs-7390460","link":"https://doi.org/10.1007/s11686-025-01213-w","journal":{"identity":"acta-parasitologica","isVorOnly":false,"title":"Acta Parasitologica"},"publishedOn":"2026-02-09 15:59:10","publishedOnDateReadable":"February 9th, 2026"},"versionCreatedAt":"2025-09-01 13:55:02","video":"","vorDoi":"10.1007/s11686-025-01213-w","vorDoiUrl":"https://doi.org/10.1007/s11686-025-01213-w","workflowStages":[]},"version":"v1","identity":"rs-7390460","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7390460","identity":"rs-7390460","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}